Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 12

Results: 21

Carrying the torch & facing new challenges.

Published in:

2020

By:

Dong, Haidong

Publication type:

Editorial

Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2665, doi. 10.1007/s00262-020-02687-5

By:

Zhang, Yun-Bin;
Liu, Shi-Jia;
Hu, Zhi-Dong;
Zhou, Ji-Xue;
Wang, Yin-zhen;
Fang, Bing;
Wong, Ka-Wing;
Xia, Fan

Publication type:

Article

Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2413, doi. 10.1007/s00262-020-02680-y

By:

Chen, Haizhu;
Wang, Daquan;
Zhong, Qiaofeng;
Tao, Yunxia;
Zhou, Yu;
Shi, Yuankai

Publication type:

Article

Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2613, doi. 10.1007/s00262-020-02652-2

By:

Stegantseva, Maria V.;
Shinkevich, Veronika A.;
Tumar, Elena M.;
Meleshko, Alexander N.

Publication type:

Article

Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2651, doi. 10.1007/s00262-020-02651-3

By:

Che, Yuxin;
Yang, Yang;
Suo, Jinguo;
An, Yujing;
Wang, Xuelian

Publication type:

Article

Characterizing caspase-1 involvement during esophageal disease progression.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2635, doi. 10.1007/s00262-020-02650-4

By:

Barber, Gillian;
Anand, Akanksha;
Katarzyna Oficjalska;
Phelan, James J.;
Heeran, Aisling B.;
Flis, Ewelina;
Clarke, Niamh E.;
Watson, Jenny A.;
Strangmann, Julia;
Flood, Brian;
O'Neill, Hazel;
O'Toole, Dermot;
MacCarthy, Finbar;
Ravi, Narayanasamy;
Reynolds, John V.;
Kay, Elaine W.;
Quante, Michael;
O'Sullivan, Jacintha;
Creagh, Emma M.

Publication type:

Article

Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2533, doi. 10.1007/s00262-020-02645-1

By:

Omura, Yusuke;
Toiyama, Yuji;
Okugawa, Yoshinaga;
Yin, Chengzeng;
Shigemori, Tsunehiko;
Kusunoki, Kurando;
Kusunoki, Yukina;
Ide, Shozo;
Shimura, Tadanobu;
Fujikawa, Hiroyuki;
Yasuda, Hiromi;
Hiro, Junichiro;
Ohi, Masaki;
Kusunoki, Masato

Publication type:

Article

Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2599, doi. 10.1007/s00262-020-02642-4

By:

Zhang, Fan;
Bai, Hua;
Gao, Ranran;
Fei, Kailun;
Duan, Jianchun;
Zhang, Zemin;
Wang, Jie;
Hu, Xueda

Publication type:

Article

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2523, doi. 10.1007/s00262-020-02641-5

By:

Yang, Yinli;
Li, Ling;
Jiang, Zhansheng;
Wang, Bin;
Pan, Zhanyu

Publication type:

Article

A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activities.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2561, doi. 10.1007/s00262-020-02640-6

By:

Wu, Fenglan;
Qiu, Yangsheng;
Xu, Yuhong

Publication type:

Article

Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2547, doi. 10.1007/s00262-020-02639-z

By:

Hu, Xintong;
Gu, Yue;
Zhao, Songchen;
Hua, Shucheng;
Jiang, Yanfang

Publication type:

Article

TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2571, doi. 10.1007/s00262-020-02638-0

By:

Guo, Qingming;
Zhao, Peng;
Zhang, Zhen;
Zhang, Jinyu;
Zhang, Zheng;
Hua, Yanan;
Han, Bin;
Li, Ning;
Zhao, Xiaowen;
Hou, Lin

Publication type:

Article

Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2513, doi. 10.1007/s00262-020-02637-1

By:

Simonaggio, A.;
Elaidi, R.;
Fournier, L.;
Fabre, E.;
Ferrari, V.;
Borchiellini, D.;
Thouvenin, J.;
Barthelemy, P.;
Thibault, C.;
Tartour, E.;
Oudard, S.;
Vano, Y. A.

Publication type:

Article

Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2453, doi. 10.1007/s00262-020-02636-2

By:

Hock, Barry D.;
McKenzie, Judith L.;
Strother, Matthew;
Goddard, Liping;
Butt, Leah;
Currie, Margaret J.

Publication type:

Article

Factors associated with ocular adverse event after immune checkpoint inhibitor treatment.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2441, doi. 10.1007/s00262-020-02635-3

By:

Kim, Yong Joon;
Lee, Jihei Sara;
Lee, Junwon;
Lee, Sung Chul;
Kim, Tae-im;
Byeon, Suk Ho;
Lee, Christopher Seungkyu

Publication type:

Article

Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2465, doi. 10.1007/s00262-020-02634-4

By:

Bunch, Brittany L.;
Kodumudi, Krithika N.;
Scott, Ellen;
Morse, Jennifer;
Weber, Amy Mackay;
Berglund, Anders E.;
Pilon-Thomas, Shari;
Markowitz, Joseph

Publication type:

Article

Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2623, doi. 10.1007/s00262-020-02632-6

By:

Liang, Jie-ying;
Xi, Shao-yan;
Shao, Qiong;
Yuan, Yun-fei;
Li, Bin-kui;
Zheng, Yun;
Wang, De-shen;
Wu, Xiao-jun;
Ding, Pei-rong;
Chen, Gong;
Li, Li-ren;
Wang, Feng-hua;
Wang, Zhi-qiang;
Pan, Zhi-zhong;
Xu, Rui-hua;
Li, Yu-hong

Publication type:

Article

The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2501, doi. 10.1007/s00262-020-02631-7

By:

Cuzzubbo, Stefania;
Banissi, Claire;
Rouchon, Marie Sophie;
Tran, Thi;
Tanchot, Corinne;
Tartour, Eric;
Carpentier, Antoine F.

Publication type:

Article

Current trends in cancer immunotherapy: a literature-mining analysis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2425, doi. 10.1007/s00262-020-02630-8

By:

Pouliliou, Stamatia;
Nikolaidis, Christos;
Drosatos, George

Publication type:

Article

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2477, doi. 10.1007/s00262-020-02628-2

By:

Komura, Naoko;
Mabuchi, Seiji;
Shimura, Kotaro;
Yokoi, Eriko;
Kozasa, Katsumi;
Kuroda, Hiromasa;
Takahashi, Ryoko;
Sasano, Tomoyuki;
Kawano, Mahiru;
Matsumoto, Yuri;
Kodama, Michiko;
Hashimoto, Kae;
Sawada, Kenjiro;
Kimura, Tadashi

Publication type:

Article

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2589, doi. 10.1007/s00262-020-02618-4

By:

Jansen, Yanina;
Kruse, Vibeke;
Corthals, Jurgen;
Schats, Kelly;
van Dam, Pieter-Jan;
Seremet, Teofila;
Heirman, Carlo;
Brochez, Lieve;
Kockx, Mark;
Thielemans, Kris;
Neyns, Bart

Publication type:

Article